Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMAGINE 1: LY2605541 vs insulin glargine in type 1 diabetes
jRCT2080221675Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin peglispro in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Eli Lilly and Company. Started Dec 2011; status: completed.
02
Drugs
insulin peglispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on jRCT2080221675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221675.